137 related articles for article (PubMed ID: 19121638)
61. Mathematical modelling of tumour acidity.
Smallbone K; Gatenby RA; Maini PK
J Theor Biol; 2008 Nov; 255(1):106-12. PubMed ID: 18725231
[TBL] [Abstract][Full Text] [Related]
62. A randomized study of chemotherapy versus biochemotherapy with chemotherapy plus Aloe arborescens in patients with metastatic cancer.
Lissoni P; Rovelli F; Brivio F; Zago R; Colciago M; Messina G; Mora A; Porro G
In Vivo; 2009; 23(1):171-5. PubMed ID: 19368145
[TBL] [Abstract][Full Text] [Related]
63. Determination of an optimal control strategy for drug administration in tumor treatment using multi-objective optimization differential evolution.
Lobato FS; Machado VS; Steffen V
Comput Methods Programs Biomed; 2016 Jul; 131():51-61. PubMed ID: 27265048
[TBL] [Abstract][Full Text] [Related]
64. A model for metastases formation.
Markovitch S
Int J Biomed Comput; 1993 Jan; 32(1):19-33. PubMed ID: 8425750
[TBL] [Abstract][Full Text] [Related]
65. Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited.
Loges S; Mazzone M; Hohensinner P; Carmeliet P
Cancer Cell; 2009 Mar; 15(3):167-70. PubMed ID: 19249675
[TBL] [Abstract][Full Text] [Related]
66. To grow or not to grow? Intermediate and paratenic hosts as helminth life cycle strategies.
Parker GA; Ball MA; Chubb JC
J Theor Biol; 2009 May; 258(1):135-47. PubMed ID: 19490873
[TBL] [Abstract][Full Text] [Related]
67. Phase II multicenter, uncontrolled trial of sorafenib in patients with metastatic breast cancer.
Bianchi G; Loibl S; Zamagni C; Salvagni S; Raab G; Siena S; Laferriere N; Peña C; Lathia C; Bergamini L; Gianni L
Anticancer Drugs; 2009 Aug; 20(7):616-24. PubMed ID: 19739318
[TBL] [Abstract][Full Text] [Related]
68. Hemoglobin-based oxygen carrier enhanced tumor oxygenation: a novel strategy for cancer therapy.
Gundersen SI; Palmer AF
Biotechnol Prog; 2008; 24(6):1353-64. PubMed ID: 19194950
[TBL] [Abstract][Full Text] [Related]
69. Model-free feedback design for a mixed cancer therapy.
Chareyron S; Alamir M
Biotechnol Prog; 2009; 25(3):690-700. PubMed ID: 19301260
[TBL] [Abstract][Full Text] [Related]
70. A mathematical model of tumour growth with Beddington-DeAngelis functional response: a case of cancer without disease.
Wei HC
J Biol Dyn; 2018 Dec; 12(1):194-210. PubMed ID: 29322865
[TBL] [Abstract][Full Text] [Related]
71. [Molecular events involved in the metastatic process].
Radvanyi F
Prog Urol; 2008 Nov; 18 Suppl 7():S167-72. PubMed ID: 19070788
[TBL] [Abstract][Full Text] [Related]
72. [Medical treatment of tumors].
Minerva Chir; 1967 Jan; 22(2):91-3. PubMed ID: 6049047
[No Abstract] [Full Text] [Related]
73. A mathematical model of drug resistance: heterogeneous tumors.
Panetta JC
Math Biosci; 1998 Jan; 147(1):41-61. PubMed ID: 9401351
[TBL] [Abstract][Full Text] [Related]
74. Derivation of Continuum Models from An Agent-based Cancer Model: Optimization and Sensitivity Analysis.
Voulgarelis D; Velayudhan A; Smith F
Curr Pharm Biotechnol; 2017; 18(15):1249-1263. PubMed ID: 29595105
[TBL] [Abstract][Full Text] [Related]
75. A mathematical model of the metastatic bottleneck predicts patient outcome and response to cancer treatment.
Szczurek E; Krüger T; Klink B; Beerenwinkel N
PLoS Comput Biol; 2020 Oct; 16(10):e1008056. PubMed ID: 33006977
[TBL] [Abstract][Full Text] [Related]
76. A mathematical model of periodically pulsed chemotherapy: tumor recurrence and metastasis in a competitive environment.
Panetta JC
Bull Math Biol; 1996 May; 58(3):425-47. PubMed ID: 8688836
[TBL] [Abstract][Full Text] [Related]
77. Implications of immune-mediated metastatic growth on metastatic dormancy, blow-up, early detection, and treatment.
Rhodes A; Hillen T
J Math Biol; 2020 Sep; 81(3):799-843. PubMed ID: 32789610
[TBL] [Abstract][Full Text] [Related]
78. Control by Viability in a Chemotherapy Cancer Model.
Serhani M; Essaadi H; Kassara K; Boutoulout A
Acta Biotheor; 2019 Sep; 67(3):177-200. PubMed ID: 30949871
[TBL] [Abstract][Full Text] [Related]
79. Multiscale modeling of the dynamic growth of cancerous tumors under the influence of chemotherapy drugs.
Farjami E; Mahjoob M
Comput Methods Biomech Biomed Engin; 2024 Jun; 27(8):919-930. PubMed ID: 37227061
[TBL] [Abstract][Full Text] [Related]
80. Dynamical interactions between multiple cancers.
Wodarz D; Anton-Culver H
Cell Cycle; 2005 Jun; 4(6):764-71. PubMed ID: 15917665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
